Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-11-12
|
5-day change | 1st Jan Change | ||
| 209,500.00 KRW | +1.21% |
|
+4.75% | +21.53% |
| Nov. 09 | Celltrion's Stekima Wins EU Backing for Expanded Use in Children | MT |
| Nov. 02 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| Market Cap | 47,857B 35.85B 32.42B 29.93B 27.09B 51.11B 3,370B 52.65B 359B 143B 1,802B 135B 132B 5,735B | P/E 2026 * |
35.4x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 50.42B 37.77M 34.16M 31.53M 28.54M 53.85M 3.55B 55.47M 378M 150M 1.9B 142M 139M 6.04B | EV / Sales 2026 * |
8.76x | EV / Sales 2027 * | 7.53x |
| Free-Float |
58.02% | Yield 2026 * |
0.37% | Yield 2027 * | 0.39% |
| 1 day | +1.21% | ||
| 1 week | +4.75% | ||
| Current month | +9.34% | ||
| 1 month | +16.65% | ||
| 3 months | -0.48% | ||
| 6 months | +14.99% | ||
| Current year | +21.53% |
| 1 week | 202,000 |  | 216,000 |
| 1 month | 173,700 | | 216,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 135,879.99 | | 239,047.62 |
| 5 years | 114,250.83 | | 239,047.62 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 51 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 69 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.21% | +4.75% | +27.30% | +52.81% | 35.34B | |
| +1.10% | +1.03% | +62.53% | +70.47% | 67.53B | |
| +1.28% | +8.79% | +16.26% | +95.16% | 60.74B | |
| +0.36% | +0.67% | +20.48% | +99.04% | 55.66B | |
| -0.57% | +8.01% | +10.80% | +110.33% | 47.97B | |
| -1.32% | +2.40% | +22.80% | +40.05% | 45.24B | |
| -1.57% | +0.53% | +171.30% | +808.88% | 39.08B | |
| -0.87% | -2.89% | +79.60% | +56.33% | 33.45B | |
| -2.04% | +9.25% | -38.88% | +397.15% | 26.49B | |
| 0.00% | +1.16% | +47.05% | +0.06% | 25.57B | |
| Average | -0.26% | +2.54% | +41.92% | +173.03% | 44B | |
| Weighted average by Cap. | -0.05% | +2.78% | +42.09% | +157.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,755B 4.31B 3.9B 3.6B 3.26B 6.15B 405B 6.33B 43.19B 17.17B 217B 16.18B 15.84B 690B | 6,605B 4.95B 4.47B 4.13B 3.74B 7.05B 465B 7.27B 49.57B 19.7B 249B 18.57B 18.17B 791B |
| Net income | 1,364B 1.02B 924M 853M 772M 1.46B 96.04B 1.5B 10.24B 4.07B 51.35B 3.83B 3.75B 163B | 1,835B 1.37B 1.24B 1.15B 1.04B 1.96B 129B 2.02B 13.77B 5.47B 69.08B 5.16B 5.05B 220B |
| Net Debt | 2,566B 1.92B 1.74B 1.6B 1.45B 2.74B 181B 2.82B 19.26B 7.65B 96.59B 7.21B 7.06B 307B | 1,849B 1.39B 1.25B 1.16B 1.05B 1.98B 130B 2.03B 13.88B 5.52B 69.62B 5.2B 5.09B 222B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | ₩209,500.00 | +1.21% | 569,041 |
| 26-11-11 | ₩207,000.00 | +1.97% | 745,716 |
| 26-11-10 | ₩203,000.00 | -3.33% | 869,506 |
| 26-11-09 | ₩210,000.00 | -0.47% | 626,672 |
| 26-11-06 | ₩211,000.00 | -1.86% | 1,036,846 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
